120 related articles for article (PubMed ID: 1379218)
1. In vitro mutagenesis of HLA-B27: single and multiple amino acid substitutions at consensus B27 sites identify distinct monoclonal antibody-defined epitopes.
el-Zaatari FA; Taurog JD
Hum Immunol; 1992 Apr; 33(4):243-8. PubMed ID: 1379218
[TBL] [Abstract][Full Text] [Related]
2. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
el-Zaatari FA; Sams KC; Taurog JD
J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
[TBL] [Abstract][Full Text] [Related]
3. In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes.
Taurog JD; el-Zaatari FA
J Clin Invest; 1988 Sep; 82(3):987-92. PubMed ID: 2458390
[TBL] [Abstract][Full Text] [Related]
4. Effect of the substitution of critical residues on the allorecognition of HLA-B27.
Ozen S; Clayberger C; Krensky AM; Benjamin R
Clin Exp Rheumatol; 1992; 10(6):583-7. PubMed ID: 1282853
[TBL] [Abstract][Full Text] [Related]
5. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
[TBL] [Abstract][Full Text] [Related]
6. Epitope mapping of human monoclonal antibodies to HLA-B27 by using natural and mutated antigenic variants.
Weyl D; Hansen T; Deschamps Y; Hannestad K; Toubert A
Hum Immunol; 1991 Aug; 31(4):271-6. PubMed ID: 1717416
[TBL] [Abstract][Full Text] [Related]
7. Antigenicity of HLA-A2 and HLA-B7. Loss and gain of serologic determinants induced by site-specific mutagenesis at residues 62 to 80.
Doménech N; Santos-Aguado J; López de Castro JA
Hum Immunol; 1991 Feb; 30(2):140-6. PubMed ID: 1708752
[TBL] [Abstract][Full Text] [Related]
8. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants.
Toubert A; Raffoux C; Boretto J; Sire J; Sodoyer R; Thurau SR; Amor B; Colombani J; Lemonnier FA; Jordan BR
J Immunol; 1988 Oct; 141(7):2503-9. PubMed ID: 2459214
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
López D; Barber DF; Villadangos JA; López de Castro JA
J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of an HLA-B27 monoclonal antibody that also reacts with a 35-kD bacterial outer-membrane protein.
Toubert A; Hamachi M; Raffoux C; Park MS; Yu DT
Clin Exp Immunol; 1990 Oct; 82(1):16-20. PubMed ID: 1698580
[TBL] [Abstract][Full Text] [Related]
12. A novel HLA-B27 allele maps B27 allospecificity to the region around position 70 in the alpha 1 domain.
Choo SY; Fan LA; Hansen JA
J Immunol; 1991 Jul; 147(1):174-80. PubMed ID: 1711072
[TBL] [Abstract][Full Text] [Related]
13. Epitope analysis of an HLA-B27-derived synthetic peptide: a possible approach to analyzing HLA class I antigens.
Zhao YP; Shi BJ; Deng HK; Yu DT; Hamachi M; Hamachi T; Zhao DF; Tang SR; Tsang JC; Park MS
Clin Exp Rheumatol; 1991; 9(3):235-9. PubMed ID: 1715248
[TBL] [Abstract][Full Text] [Related]
14. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.
Calvo V; Rojo S; López D; Galocha B; López de Castro JA
J Immunol; 1990 May; 144(10):4038-45. PubMed ID: 1692072
[TBL] [Abstract][Full Text] [Related]
15. Anti-HLA-B7/HLA-B44 strong cross immunoreactivity observed in flow cytometry HLA-B27 immunotyping.
Francois F; Waeckel L; Berger AE; Lambert C
Cytometry A; 2024 May; 105(5):376-381. PubMed ID: 38379087
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric HLA-B27 screening: cross-reactivity patterns of commercially available anti-HLA-B27 monoclonal antibodies with other HLA-B antigens.
Levering WH; Wind H; Sintnicolaas K; Hooijkaas H; Gratama JW
Cytometry B Clin Cytom; 2003 Jul; 54(1):28-38. PubMed ID: 12827665
[TBL] [Abstract][Full Text] [Related]
17. Delineation of determinants on HLA-B7 and HLA-B27 that are necessary for cytolytic T cell recognition by using inter- and intra-domain recombinants.
Healy F; Toubert A; Gomard E; Jordan BR; Levy JP
J Immunol; 1989 Oct; 143(7):2357-63. PubMed ID: 2476507
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of HLA-B7 and HLA-B27 alleles is associated with B7-restricted immunodominant responses following influenza infection.
Akram A; Inman RD
Eur J Immunol; 2013 Dec; 43(12):3254-67. PubMed ID: 24113999
[TBL] [Abstract][Full Text] [Related]
19. One allogeneic cytolytic T lymphocyte clone distinguishes three different HLA-B27 subtypes: identification of amino acid residues influencing the specificity and avidity of recognition.
Aparicio P; Vega MA; López de Castro JA
J Immunol; 1985 Nov; 135(5):3074-81. PubMed ID: 2413111
[TBL] [Abstract][Full Text] [Related]
20. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
Villadangos JA; Galocha B; López de Castro JA
J Immunol; 1994 Mar; 152(5):2317-23. PubMed ID: 7510742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
